HITM HEPATIC IMMUNOTHERAPY FOR METASTASES
USPTO Trademark Record · Serial No. 85393437
Trademark details
It was initially claimed by PROSPECT CHARTERCARE, LLC on 20110809.
That brand applies to the following goods and services:Medical services, namely, human cancer treatment involving the administration of genetically modified patient T cells delivered regionally, directly into the liver.
Currently that trademark is represented by trademark attorney(s): Paul A. Campellone.
You can learn more about that trademark on the USPTO website: View the USPTO record
Services available
Questions about this trademark?
If you have questions or issues related to the HITM HEPATIC IMMUNOTHERAPY FOR METASTASES trademark — or to trademarks in general — our trademark attorneys can help. No appointment needed: call us or request a free estimate.
Register a Trademark Get a Free Estimate
